Nanopath, a Cambridge, Mass.-based women’s health diagnostics company, raised $10 million in Series A funding, Per Axios. Norwest Venture Partners and the Medtech Convergence Fund co-led, and were joined by Gingerbread Capital and Green D Ventures.
Nanopath Raises $10M in A Round
